AlpInvest Partners’s NEVRO CORP. NVRO Stock Holding History

AlpInvest Partners’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,854	Closed	-$335K	–	10
2017 Q4	$335K	Buy	+4,854	New	+$388K	1.19%	8

Other funds holding NVRO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

AlpInvest Partners's NVRO Position: Q1 2018 in Review

AlpInvest Partners sold out of NEVRO CORP. (NVRO) in Q1 2018, closing a stake of 4,854 shares — an estimated $335K sold.

AlpInvest Partners first reported a position in NVRO in Q4 2017 and held it in 1 quarter. The position peaked at $335K in Q4 2017. 197 funds tracked by Wall St. Rank hold NVRO as of Q1 2018.

AlpInvest Partners reported no remaining NEVRO CORP. position as of Q1 2018 after selling out during the quarter.
AlpInvest Partners sold 4,854 NEVRO CORP. shares in Q1 2018, an estimated $335K.
AlpInvest Partners first reported a position in NEVRO CORP. in Q4 2017 and held it in 1 quarter.
AlpInvest Partners's NEVRO CORP. position peaked at $335K in Q4 2017.
197 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2018.

Based on AlpInvest Partners's 13F filing for Q1 2018, filed 14 May 2018.